当前位置: X-MOL 学术Ann. Lab. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Development and Validation of a Novel Isotope Dilution-Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry Method for Serum C-Peptide.
Annals of Laboratory Medicine ( IF 4.0 ) Pub Date : 2024-08-23 , DOI: 10.3343/alm.2024.0072
Sung-Eun Cho 1, 2 , Jungsun Han 1, 2 , Juyoung You 1, 2 , Jun Hyung Lee 1, 2 , Ahram Yi 1, 2 , Sang Gon Lee 2 , Eun Hee Lee 2
Affiliation  

Background Mass spectrometry (MS) methods exhibit higher accuracy and comparability in measuring serum C-peptide concentrations than immunoassays. We developed and validated a novel isotope dilution-ultraperformance liquid chromatography-tandem MS (ID-UPLC-MS/MS) assay to measure serum C-peptide concentrations. Methods Sample pretreatment involved solid-phase extraction, ion-exchange solid-phase extraction, and derivatization with 6-aminoquinolyl-N-hydroxysuccinimidylcarbamate (Cayman Chemical, Ann Arbor, Michigan, USA). We used an ExionLC UPLC system (Sciex, Framingham, MA, USA) and a Sciex Triple Quad 6500+ MS/MS system (Sciex) for electrospray ionization in positive-ion mode with multiple charge states of [M+3H]3+ and multiple reaction monitoring transitions. The total run time was 50 mins, and the flow rate was 0.20 mL/min. We evaluated the precision, trueness, linearity, lower limit of quantitation (LLOQ), carryover, and matrix effects. Method comparison with electrochemiluminescence immunoassay (ECLIA) was performed in 138 clinical specimens. Results The intra- and inter-run precision coefficients of variation were <5% and the bias values for trueness were <4%, which were all acceptable. The verified linear interval was 0.050-15 ng/mL, and the LLOQ was 0.050 ng/mL. No significant carryover or matrix effects were observed. The correlation between this ID-UPLC-MS/MS method and ECLIA was good (R=0.995, slope=1.564); however, the ECLIA showed a positive bias (51.8%). Conclusions The developed ID-UPLC-MS/MS assay shows acceptable performance in measuring serum C-peptide concentrations. This will be useful in situations requiring accurate measurement of serum C-peptide in clinical laboratories.

中文翻译:


开发和验证一种用于血清 C 肽的新型同位素稀释-超高效液相色谱-串联质谱方法。



背景质谱 (MS) 方法在测量血清 C 肽浓度方面表现出比免疫测定更高的准确性和可比性。我们开发并验证了一种新型同位素稀释-超高效液相色谱-串联 MS (ID-UPLC-MS/MS) 测定法,用于测量血清 C 肽浓度。方法 样品预处理包括固相萃取、离子交换固相萃取和用 6-氨基喹啉基-N-羟基琥珀酰亚胺基氨基甲酸酯(Cayman Chemical,美国密歇根州安娜堡)衍生化。我们使用ExionLC UPLC系统(Sciex,美国马萨诸塞州弗雷明汉)和Sciex Triple Quad 6500+ MS/MS系统(Sciex)在正离子模式下进行电喷雾电离,具有[M+3H]3+的多个电荷态和多个反应监测通道。总运行时间为 50 min,流速为 0.20 mL/min。我们评估了精密度、正确度、线性、定量下限 (LLOQ)、残留和基质效应。在 138 例临床标本中进行了与电化学发光免疫测定 (ECLIA) 的方法比较。结果 运行内和运行间精密度变异系数为 <5%,正确度偏差值为 <4%,均可接受。验证的线性区间为 0.050-15 ng/mL,LLOQ 为 0.050 ng/mL。未观察到显著的残留或基质效应。该 ID-UPLC-MS/MS 方法与 ECLIA 之间的相关性良好 (R=0.995,斜率=1.564);然而,ECLIA 显示出正偏倚 (51.8%)。结论 开发的 ID-UPLC-MS/MS 分析在测量血清 C 肽浓度方面显示出可接受的性能。这在临床实验室需要准确测量血清 C 肽的情况下非常有用。
更新日期:2024-08-23
down
wechat
bug